(Q39640281)

13 September 2017

Virologic efficacy of boosted double versus boosted single protease inhibitor therapy (English)

1 reference

13 September 2017

0 references

4

Soo-Yon Rhee

1 reference

13 September 2017

5

Robert W Shafer

1 reference

Mark Johannes van der Laan

13 September 2017

series ordinal

3

object named as

Mark J van der Laan

1 reference

13 September 2017

1

Maya L Petersen

1 reference

13 September 2017

Yue Wang

2

1 reference

13 September 2017

W Jeffrey Fessel

series ordinal

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

13 September 2017

1 reference

13 September 2017

21

1 reference

13 September 2017

12

1 reference

13 September 2017

1547-1554

1 reference

Marginal structural models and causal inference in epidemiology

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Deletion/substitution/addition algorithm in learning with applications in genomics

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442039

10.1097/QAD.0B013E32825A69A8

21 August 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

13 September 2017

PubMed publication ID

17630549

1 reference